These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1126 related items for PubMed ID: 23684708

  • 21. Unraveling the role of FOXQ1 in colorectal cancer metastasis.
    Abba M, Patil N, Rasheed K, Nelson LD, Mudduluru G, Leupold JH, Allgayer H.
    Mol Cancer Res; 2013 Sep; 11(9):1017-28. PubMed ID: 23723077
    [Abstract] [Full Text] [Related]

  • 22. Aminopeptidase A initiates tumorigenesis and enhances tumor cell stemness via TWIST1 upregulation in colorectal cancer.
    Chuang HY, Jiang JK, Yang MH, Wang HW, Li MC, Tsai CY, Jhang YY, Huang JC.
    Oncotarget; 2017 Mar 28; 8(13):21266-21280. PubMed ID: 28177885
    [Abstract] [Full Text] [Related]

  • 23. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.
    Wang T, Li Y, Wang W, Tuerhanjiang A, Wu Z, Yang R, Yuan M, Ma D, Wang W, Wang S.
    Hum Pathol; 2014 Sep 28; 45(9):1839-46. PubMed ID: 24974259
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.
    Liu C, Luo J, Zhao YT, Wang ZY, Zhou J, Huang S, Huang JN, Long HX, Zhu B.
    Int J Mol Med; 2018 Jul 28; 42(1):461-470. PubMed ID: 29693173
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
    Khan MA, Tania M, Wei C, Mei Z, Fu S, Cheng J, Xu J, Fu J.
    Oncotarget; 2015 Aug 14; 6(23):19580-91. PubMed ID: 26023736
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG.
    Hepatology; 2013 Oct 14; 58(4):1349-61. PubMed ID: 23696034
    [Abstract] [Full Text] [Related]

  • 30. Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer.
    Kahlert C, Lerbs T, Pecqueux M, Herpel E, Hoffmeister M, Jansen L, Brenner H, Chang-Claude J, Bläker H, Kloor M, Roth W, Pilarsky C, Rahbari NN, Schölch S, Bork U, Reissfelder C, Weitz J, Aust D, Koch M.
    Int J Cancer; 2015 Nov 01; 137(9):2104-13. PubMed ID: 25951369
    [Abstract] [Full Text] [Related]

  • 31. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
    Franke FC, Müller J, Abal M, Medina ED, Nitsche U, Weidmann H, Chardonnet S, Ninio E, Janssen KP.
    Cell Mol Gastroenterol Hepatol; 2019 Nov 01; 7(1):33-53. PubMed ID: 30480076
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
    Alqurashi N, Gopalan V, Smith RA, Lam AK.
    Hum Pathol; 2013 Oct 01; 44(10):2089-96. PubMed ID: 23773481
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Twist mediates an aggressive phenotype in human colorectal cancer cells.
    Deng JJ, Zhang W, Xu XM, Zhang F, Tao WP, Ye JJ, Ge W.
    Int J Oncol; 2016 Mar 01; 48(3):1117-24. PubMed ID: 26782761
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Down-regulation of CDH1 is associated with expression of SNAI1 in colorectal adenomas.
    Kroepil F, Fluegen G, Totikov Z, Baldus SE, Vay C, Schauer M, Topp SA, Esch JS, Knoefel WT, Stoecklein NH.
    PLoS One; 2012 Mar 01; 7(9):e46665. PubMed ID: 23029563
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
    Shen ZY, Fang Y, Zhen L, Zhu XJ, Chen H, Liu H, Jiang B, Li GX, Deng HJ.
    Cancer Genet; 2016 Apr 01; 209(4):143-53. PubMed ID: 26975699
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.